August 31, 2026

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and 9.54% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline of genetic medicines and..

Oscar Health, Inc. (OSCR) Stock Analysis: Is the Recent 70.4% Revenue Growth a Sign of More to Come?

Oscar Health, Inc. (NYSE: OSCR), a dynamic player in the healthcare technology sector, has caught the eye of investors with its notable 70.4% revenue growth. This..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring the Biotech’s Steady Path with a $9.81 Billion Market Cap

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the biotechnology sector with a market capitalization of $9.81 billion...

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 19.6% Potential Upside in Healthcare Services

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, particularly within the medical care facilities industry, offering a diverse range of infusion services..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Gem with 43% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with its promising outlook in the biotechnology sector. As a company focused on developing innovative..

Solventum Corporation (SOLV) Stock Analysis: Understanding the Healthcare Giant’s 3.08% Potential Upside

In the world of healthcare investments, Solventum Corporation (SOLV) stands out as a promising player commanding a market capitalization of $15.51 billion. Specializing in medical instruments..

Rhythm Pharmaceuticals (RYTM): Investor Outlook on a 30.81% Potential Upside in Biotechnology

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a prominent player in the biopharmaceutical sector, offers a compelling investment opportunity for those interested in the rapidly evolving landscape of..

Viatris Inc. (VTRS) Stock Analysis: Exploring Its 13% Upside Potential and Dividend Appeal

Viatris Inc. (NASDAQ: VTRS) stands as a formidable player in the healthcare sector, particularly in the drug manufacturing industry, where it specializes in both specialty and..

TransMedics Group, Inc. (TMDX) Investor Outlook: Harnessing a 10% Upside Potential in Medical Devices

TransMedics Group, Inc. (NASDAQ: TMDX), a trailblazer in the healthcare sector, is making waves with its innovative approach to organ transplant therapy. Known for its Organ..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating a Challenging Market with Strategic Insights

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in the manufacturing of medical devices, catering to a diverse range of medical..

Novartis AG (NVS): Investor Outlook on a Healthcare Giant with Promising Upside

Novartis AG (NYSE: NVS), a Swiss-based titan in the healthcare sector, has long been a stalwart in the pharmaceutical industry. With a robust market capitalization of..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Challenges with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL) operates in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $14.04 billion,..

Alkermes plc (ALKS) Stock Analysis: Exploring an 18% Potential Upside with a Solid Revenue Growth Story

Alkermes plc (NASDAQ: ALKS), an innovative player in the biopharmaceutical sector, presents an intriguing opportunity for investors with its current market position. Headquartered in Dublin, Ireland,..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking a 40.78% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a notable player in the biotechnology sector, focused on developing therapies for severe and rare diseases. With a market..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating a Healthcare Giant with 11.67% Upside Potential

Fresenius Medical Care AG (FMS), a key player in the healthcare sector, specializes in providing dialysis and related services across the globe. With a market cap..

Ionis Pharmaceuticals (IONS) Stock Analysis: Evaluating a 44% Potential Upside in the Biotech Sector

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands at the forefront of the biotechnology industry with its innovative RNA-targeted medicines. Headquartered in Carlsbad, California, this healthcare sector player..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility in Biotechnology with a Potential 22.73% Downside

For investors focusing on the dynamic biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) presents a compelling yet complex opportunity set against the backdrop of an ever-evolving healthcare..

Bausch + Lomb Corporation (BLCO) Stock Report: Analyzing a 9.10% Revenue Growth in the Healthcare Sector

Investors keeping a close eye on the healthcare sector might find Bausch + Lomb Corporation (NYSE: BLCO) an intriguing prospect. As a key player in the..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Potential Upside Amidst Robust Revenue Growth

Mettler-Toledo International Inc. (NYSE: MTD), a key player in the Diagnostics & Research sector, commands attention with its robust $28.02 billion market capitalization. Operating from its..

Grifols, S.A. (GRFS) Stock Analysis: A Potential 41% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS) presents a compelling investment opportunity in the healthcare sector, known for its robust portfolio of plasma-derived medicines. Headquartered in Barcelona, Spain, Grifols..

Search

Funds

August 31, 2026

Search

Funds

August 31, 2026

FTSE 100

Funds